日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting metabolic vulnerabilities: REV-ERB agonist SR9009 potentiates sorafenib efficacy in liver cancer.

靶向代谢脆弱性:REV-ERB 激动剂 SR9009 可增强索拉非尼在肝癌中的疗效。

Sabbioni Silvia, Guerriero Paola, Shankaraiah Ram C, Masatti Laura, Michilli Angelo, Bassi Cristian, D'Abundo Lucilla, Moshiri Farzaneh, De Siena Bruno, Simoni Edi, Astolfi Laura, Gramantieri Laura, Roncarati Roberta, Elamin Bahaeldin K, Bonora Massimo, Pinton Paolo, Croce Carlo M, Negrini Massimo, Callegari Elisa

Dinutuximab beta effectively treats Ewing sarcoma when combined with chemotherapy.

Dinutuximab beta 与化疗联合使用可有效治疗尤文氏肉瘤。

Frapolli Roberta, Meroni Marina, Bello Ezia, Pirona Lorenza, Callegari Elisa, Kebede Valentina, Pellerani Isabella, Canesi Simone, Scanziani Eugenio, Dirksen Uta, Angelico Patrizia, Biondi Stefano, Malinverno Matteo

The Effects of Variant Allele Frequency for EGFR Mutation on Early Tumor Shrinkage and Deepness of Response to Osimertinib in Patients with Metastatic Non-Small Cell Lung Cancer: An Exploratory Analysis

EGFR突变变异等位基因频率对转移性非小细胞肺癌患者早期肿瘤缩小及奥希替尼治疗反应深度的影响:一项探索性分析

Bronte, Giuseppe; Carnevale, Aldo; Ciancetta, Antonella; Cosi, Donato Michele; Fragale, Cristina; Ciarrocchi, Stefania; Di Guglielmo, Maria Luisa; Tinelli, Giovanna; Mindicini, Noemi; Battara, Lucia; D'Abundo, Lucilla; Callegari, Elisa; Lanza, Giovanni; Gabriele, Deborah; Gafà, Roberta; Santini, Alessandra; Negrini, Massimo; Calabrò, Luana

TG221: An Experimental Model for Liver Cancer Prevention and Treatment Approaches

TG221:肝癌预防和治疗方法的实验模型

Callegari, Elisa; Michilli, Angelo; Moshiri, Farzaneh; De Siena, Bruno; Gramantieri, Laura; Negrini, Massimo; Sabbioni, Silvia

Transcriptomic Analysis Reveals an NRF2-Mediated Redox and Metabolic Reprogramming in Sorafenib-Resistant Hepatocellular Carcinoma Cells

转录组分析揭示索拉非尼耐药肝细胞癌细胞中NRF2介导的氧化还原和代谢重编程

Michilli, Angelo; Bassi, Cristian; Moshiri, Farzaneh; De Siena, Bruno; Marinaro, Rosaria; Callegari, Elisa; Negrini, Massimo; Sabbioni, Silvia

Erratum: miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models

更正:miR-199a-3p 可增强帕博西尼在肝癌模型中的抗肿瘤活性

Callegari, Elisa; Guerriero, Paola; Bassi, Cristian; D'Abundo, Lucilla; Frassoldati, Antonio; Simoni, Edi; Astolfi, Laura; Silini, Enrico Maria; Sabbioni, Silvia; Negrini, Massimo

Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer

支气管灌洗液分子检测在肺癌诊断和预测评估中的应用

Roncarati, Roberta; Lupini, Laura; Miotto, Elena; Saccenti, Elena; Mascetti, Susanna; Morandi, Luca; Bassi, Cristian; Rasio, Debora; Callegari, Elisa; Conti, Valentina; Rinaldi, Rosa; Lanza, Giovanni; Gafà, Roberta; Papi, Alberto; Frassoldati, Antonio; Sabbioni, Silvia; Ravenna, Franco; Casoni, Gian L; Negrini, Massimo

MicroRNAs in Animal Models of HCC

肝细胞癌动物模型中的microRNA

Fornari, Francesca; Gramantieri, Laura; Callegari, Elisa; Shankaraiah, Ram C; Piscaglia, Fabio; Negrini, Massimo; Giovannini, Catia

Animal Models of Hepatocellular Carcinoma Prevention

肝细胞癌预防的动物模型

Shankaraiah, Ram C; Gramantieri, Laura; Fornari, Francesca; Sabbioni, Silvia; Callegari, Elisa; Negrini, Massimo

Role of microRNAs in hepatocellular carcinoma: a clinical perspective

微小RNA在肝细胞癌中的作用:临床视角

Callegari, Elisa; Elamin, Bahaeldin K; Sabbioni, Silvia; Gramantieri, Laura; Negrini, Massimo